DEA Schedule CII

Strength

5; 5; 5; 5 mg/1; mg/1; mg/1; mg/1

NDC

64850050501

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

4/22/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA211352

On Market Since

12/29/2022

Pharmacological Classes

Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulation
Central Nervous System Stimulation
Central Nervous System Stimulation
Central Nervous System Stimulation

Price History

1W

0.0%

1M

-0.7%

3M

-3.7%

6M

-5.7%

1Y

-8.5%

3Y

N/A

5Y

N/A

All

-3.1%